NCT05360810

Brief Summary

The most common adverse event in endoscopic procedures is hypoxia. Different airway devices have been investigated in the literature to prevent hypoxia. This study aimed to compare the efficacy and procedural performance of two different airway (GLT and WNJ) devices in ERCP procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 4, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

May 10, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2022

Completed
Last Updated

September 15, 2022

Status Verified

September 1, 2022

Enrollment Period

3 months

First QC Date

April 29, 2022

Last Update Submit

September 14, 2022

Conditions

Keywords

Wei Nasal Jet TubeGastro-laryngeal tubeERCPAirway ComplicationHipoxia

Outcome Measures

Primary Outcomes (2)

  • Hypoxia İncidence

    Hypoxia is defined as SpO2 \<92% at any time.

    Intra-operative; after device insertion

  • Endoscopist Satisfaction Analysis: Score

    It is determined by the endoscopist according to the endoscopy satisfaction scale according to the maneuverability of the duodenoscope and the number of insertion attempts. (0-10 Points) The endocopist satisfaction score is scored on a minimum score of 0 and a maximum of 10 points. A score of 0 means I am not satisfied at all, a score of 10 means very satisfied. A higher score indicates higher satisfaction.

    Intra-operative, during the procedure

Secondary Outcomes (3)

  • Blood staining on the device

    Immediately after removing the supraglottic airway device

  • Presence of sore throat

    One hour after extubation

  • Incidence of hypercapnia

    Intra-operative; after device insertion

Study Arms (2)

Wei Nasal Jet Tube Group (Group W)

ACTIVE COMPARATOR

After induction of anesthesia, the Wei Nasal Jet Tube was placed in the patients.

Device: Wei Nasal Jet Tube

Gastro-Laryngeal Tube Group (Group G)

ACTIVE COMPARATOR

After the induction of anesthesia, the Gastro Laryngeal Tube was placed in the patients.

Device: Gastro Laryngeal Tube

Interventions

comparing efficiency and complications of second generation airway devices which can use for gastrointestinally procedures airway devices which can use for gastrointestinal procedures

Also known as: Comparison of LMA Gastro Airway® and Gastro-Laryngeal Tube in patients who will ERCP procedures.
Wei Nasal Jet Tube Group (Group W)

comparing efficiency and complications of second generation airway devices which can use for gastrointestinally procedures

Also known as: Comparison of LMA Gastro Airway® and Gastro-Laryngeal Tube in patients who will ERCP procedures.
Gastro-Laryngeal Tube Group (Group G)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA Physical Status 1-2
  • Elective Procedures
  • Body mass index 18.5 - 35 kg/m2

You may not qualify if:

  • High risk of pulmonary aspiration
  • Pregnancy
  • Anesthesic drug allergies
  • Difficult airway or facial deformities
  • Height \<155 cm
  • Alcohol or narcotic drug usage
  • Restrictive or obstructive pulmonary diseases
  • Hepatic cardiac or renal failure
  • Neurologic or cognitive deficiencies.
  • Previous cervical surgery or cervical radiotherapy
  • Previous esophagus surgery
  • Psychotic problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

EpistaxisBronchial Spasm

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and SymptomsBronchial Diseases

Study Officials

  • Harun Uysal, M.D.

    Bezmialem Vakif University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single (Participant) closed envelope technique
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 29, 2022

First Posted

May 4, 2022

Study Start

May 10, 2022

Primary Completion

August 1, 2022

Study Completion

August 15, 2022

Last Updated

September 15, 2022

Record last verified: 2022-09

Locations